Modus Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Modus Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-313	Closed	-$52.8K	–	206
2025 Q4	$52.8K	Buy	+313	New	+$50.8K	0.01%	176
2025 Q1	–	Sell	-313	Closed	-$41.4K	–	190
2024 Q4	$41.4K	Buy	+313	New	+$44K	0.01%	160
2023 Q4	–	Sell	-2,690	Closed	-$329K	–	100
2023 Q3	$329K	Hold	2,690	–	–	0.14%	87
2023 Q2	$342K	Buy	2,690 +4	+0.1%	+$520	0.15%	84
2023 Q1	$347K	Hold	2,686	–	–	0.16%	79
2022 Q4	$353K	Hold	2,686	–	–	0.17%	80
2022 Q3	$314K	Hold	2,686	–	–	0.17%	78
2022 Q2	$316K	Hold	2,686	–	–	0.16%	78
2022 Q1	$350K	Hold	2,686	–	–	0.15%	78
2021 Q4	$410K	Hold	2,686	–	–	0.17%	74
2021 Q3	$434K	Hold	2,686	–	–	0.19%	71
2021 Q2	$440K	Hold	2,686	–	–	0.19%	71
2021 Q1	$404K	Hold	2,686	–	–	0.19%	73
2020 Q4	$407K	Hold	2,686	–	–	0.21%	66
2020 Q3	$364K	Buy	+2,686	New	+$364K	0.21%	66

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Modus Advisors's IBB Position: Q1 2026 in Review

Modus Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 313 shares — an estimated $52.8K sold.

Modus Advisors first reported a position in IBB in Q3 2020 and held it in 15 quarters. The position peaked at $440K in Q2 2021. 923 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Modus Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Modus Advisors sold 313 iShares Biotechnology ETF shares in Q1 2026, an estimated $52.8K.
Modus Advisors first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 15 quarters.
Modus Advisors's iShares Biotechnology ETF position peaked at $440K in Q2 2021.
923 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.